Racial differences in the incidence of chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 1, 2012, Pages 101-107

  Muntner, Paul ^a,b   Newsome, Britt ^c   Kramer, Holly ^d   Peralta, Carmen A ^e   Kim, Yongin ^c   Jacobs, David R ^f   Kiefe, Catarina I ^g   Lewis, Cora E ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b and Clinical Center   (United States)

^c Denver Nephrologists PC   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RACE DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AFRICAN AMERICANS; ALBUMINURIA; CHRONIC DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; YOUNG ADULT;

EID: 84863178887     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06450611     Document Type: Article

References (36)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Kramer H, Palmas W, Kestenbaum B, Cushman M, Allison M, Astor B, Shlipak M: Chronic kidney disease prevalence estimates among racial/ethnic groups: The Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol 3: 1391-1397, 2008
3. McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G: Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17: 1710-1715, 2006
4. Islam TM, Fox CS, Mann D, Muntner P: Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol 10: 17, 2009
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
6. United States Renal Data System (USRDS): USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
7. Hsu CY, Vittinghoff E, Lin F, Shlipak MG: The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141: 95-101, 2004
8. Norris K, Mehrotra R, Nissenson AR: Racial differences in mortality and ESRD. Am J Kidney Dis 52: 205-208, 2008
9. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 13: 1338-1349, 2002
10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, RothD: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
12. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ: CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41: 1105-1116, 1988
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
14. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH National Kidney Disease Education Program Laboratory Working Group: Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52: 5-18, 2006
15. Bash LD, Coresh J, Köttgen A, Parekh RS, Fulop T, Wang Y, Astor BC: Defining incident chronic kidney disease in the research setting: The ARIC Study. Am J Epidemiol 170: 414-424, 2009
16. KDOQI Working Group: Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39: S46-S75, 2002
17. Zhang Z, Sun J: Interval censoring. Stat Methods Med Res 19: 53-70, 2010
18. Allison P: Estimating parametric regression models with PROC LIFEREG. In: Survival Analysis Using SAS: A Practical Guide, Cary, NC, SAS Publishing, 2008, pp 61-110
19. Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM: When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol 162: 267-278, 2005
20. Jacobs DR, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC: Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 155: 1114-1119, 2002
21. Rubin DB: MultipleImputation for Nonresponsein Surveys, New York, John Wiley & Sons, Inc, 1987
22. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J: End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277: 1293-1298, 1997
23. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151: 1359-1364, 1991
24. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM: White/black racial differences in risk of end-stage renal disease and death. Am J Med 122: 672-678, 2009
25. Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG: Racial differences in the competing risks of mortality and ESRD after acute myo-cardial infarction. Am J Kidney Dis 52: 251-261, 2008
26. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 13: 2363-2370, 2002
27. Muntner P, Arshad A, Morse SA, Patel DA, Manapatra PD, Reisin E, Aguilar EA, Chen W, Srinivasan S, Berenson GS: End-stage renal disease in young black males in a black-white population: Longitudinal analysis of the Bogalusa Heart Study. BMC Nephrol 10: 40, 2009
28. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, Brancati FL: A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: The Atherosclerosis Risk in Communities study. Arch Intern Med 159: 1777-1783, 1999
29. McFarland DD, Cobb S: Causal interpretations from cross-sectional data. An examination of the stochastic processes involved in the relationship between a personality characteristic and coronary heart disease. J Chronic Dis 20: 393-406, 1967
30. Gordis L: Epidemiology, 1st Ed., Philadelphia, W.B. Saunders Company, 1997
31. Mehrotra R, Kermah D, Fried L, Adler S, Norris K: Racial differences in mortality among those with CKD. J Am Soc Nephrol 19: 1403-1410, 2008
32. Foley RN, Wang C, Ishani A, Collins AJ: NHANES III: Influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol 18: 2575-2582, 2007
33. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ: Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 18: 1299-1306, 2007
34. James GD, Sealey JE, Alderman M, Ljungman S, Mueller FB, Pecker MS, Laragh JH: A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens 1: 124-131, 1988
35. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188, 2005
36. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60mL/min/1.73 m2. Am J Kidney Dis 56: 486-495, 2010